Community-Acquired Skin Infections in the Age of Methicillin-Resistant Organisms
Final Contract Report
The Agency for Healthcare Research and Quality's Practice-Based Research Networks in Iowa conducted a 2-year project related to infections caused by community acquired methicillin-resistant Staphylococcus aureus. "Community-Acquired Skin Infections in the Age of Methicillin-Resistant Organisms"is the final contract report for the project.
Prepared for the Agency for Healthcare Research and Quality (AHRQ) by the Iowa Research Network Practices, University of Iowa under Contract No. HHSA-290-2007-10012.
Prepared by: Barcey T. Levy, Ph.D., M.D. and Jeanette Daly, Ph.D.; Iowa Research Network Practices, University of Iowa
Medical Record Review Form
Education of Medical Record Abstractors
Implications for Practice
Table 1. Summary of Interventions by Office
Table 2. Skin Infection Forms Received by Study Site
Table 3. Demographic Characteristics by Clinic Site
Table 4. Demographic Summary of Retrospective Study Subjects
Table 5. Skin Infection Type, Incision and Drainage Done, Culture Sent, Initial Antibiotic Prescribed, and MRSA in Wound for Retrospective Subjects
Table 6. Treatment According to Infection Type, Retrospective Data
Table 7. Abscess Treatment by Incision and Drainage Done Versus Not, Retrospective Data
Table 8. Time to Resolution of Infection (Days), Univariate Analyses Retrospective Information
Table 9. Time to Resolution Using Cox Proportional Hazards Regression for Retrospective Data
Table 10. Prospective Skin Forms Returned by Clinic
Table 11. Demographic Information from Prospective Skin and Soft Tissue Infection Forms
Table 12. Skin Infection Type, Treatment Characteristics, and Whether MRSA Cultured for Prospective Patients
Table 13. Comparison of Retrospective and Prospective Data, All Cases
Table 14. Comparison of Retrospective and Prospective Treatments for Any Infection That Had an Abscess
Table 15. Time to Resolution According to Various Characteristics, Retrospective, Prospective, and All Cases
Figure 1. Map of Offices Participating in CA-MRSA Study
Figure 2. Antibiotics Prescribed at Initial Visit
Figure 3. Antibiotics Prescribed at First Follow-Up Visit
Figure 4. Antibiotics Prescribed at Initial Prospective Visit
The findings and conclusions in this document are those of the author(s), who are responsible for its content, and do not necessarily represent the views of the Agency for Healthcare Research and Quality (AHRQ). No statement in this report should be construed as an official position of AHRQ or of the U.S. Department of Health and Human Services.
This document is in the public domain and may be used and reprinted without permission. AHRQ appreciates citation of the source.